| 1 |
32922493 | A Preliminary Study of NER and MMR Pathways Involved in Chemotherapy Response in Bladder Transitional Cell Carcinoma: Impact on progression-free survival. | 2020 Winter |
1 |
| 2 |
31235597 | EBV infection is associated with histone bivalent switch modifications in squamous epithelial cells. | 2019 Jul 9 |
1 |
| 3 |
30594176 | MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway. | 2018 Dec 29 |
5 |
| 4 |
28536927 | Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours. | 2017 Aug |
2 |
| 5 |
27823983 | Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts. | 2016 Nov 22 |
1 |
| 6 |
26191250 | DNA methylation of hMLH1 correlates with the clinical response to cisplatin after a surgical resection in Non-small cell lung cancer. | 2015 |
8 |
| 7 |
24289605 | No relationship between the amount of DNA damage and the level of hMLH1 and RASSF1A gene expression in bladder cancer cells treated with cisplatin and gemcitabine. | 2013 |
3 |
| 8 |
22249249 | Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling. | 2012 Oct 18 |
1 |
| 9 |
22737591 | Molecular signaling mechanisms of apoptosis in hereditary non-polyposis colorectal cancer. | 2012 Jun 15 |
1 |
| 10 |
21064154 | A CRM1-dependent nuclear export pathway is involved in the regulation of MutLĪ± subcellular localization. | 2011 Feb |
1 |
| 11 |
21875463 | [Reversal effect of 5-Aza-dc on cisplatin-resistance in human NSCLC cells in vitro]. | 2011 May |
2 |
| 12 |
20470425 | Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin. | 2010 May 14 |
1 |
| 13 |
23136600 | Human MLH1 status can potentially predict cisplatin sensitivity but not microsatellite instability in head and neck squamous cell carcinoma cells. | 2010 Jan |
4 |
| 14 |
19259094 | Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo. | 2009 Mar 10 |
2 |
| 15 |
19603033 | MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition. | 2009 Jul 21 |
4 |
| 16 |
18683754 | [Influence of mifepristone on DNA repair genes and cisplatin sensitivity in human ovarian cancer drug-resistance cells]. | 2008 Feb |
1 |
| 17 |
19175039 | Analysis of hMLH1 and hMSH2 expression in cisplatin-treated ovarian cancer patients. | 2008 Dec |
2 |
| 18 |
17276589 | Hsp27, Hsp70 and mismatch repair proteins hMLH1 and hMSH2 expression in peripheral blood lymphocytes from healthy subjects and cancer patients. | 2007 Jul 8 |
1 |
| 19 |
16143448 | DNA damage and repair in peripheral blood lymphocytes from healthy individuals and cancer patients: a pilot study on the implications in the clinical response to chemotherapy. | 2006 Jul 28 |
1 |
| 20 |
16716446 | Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients. | 2006 Jul |
1 |
| 21 |
16273226 | Presence of MLH1 protein aggravates the potential of the HSP90 inhibitor radicicol to sensitize tumor cells to cisplatin. | 2005 Dec |
6 |
| 22 |
15506976 | Epigenetic approaches to cancer therapy. | 2004 Dec |
3 |
| 23 |
12736115 | Loss of hMLH1 expression correlates with improved survival in stage III-IV ovarian cancer patients. | 2003 May |
1 |
| 24 |
14555508 | Reduced MLH1 expression after chemotherapy is an indicator for poor prognosis in esophageal cancers. | 2003 Oct 1 |
4 |
| 25 |
12023887 | Ascorbate up-regulates MLH1 (Mut L homologue-1) and p73: implications for the cellular response to DNA damage. | 2002 Jun 1 |
3 |
| 26 |
12441268 | Retention of activity by the new generation platinum agent AMD0473 in four human tumour cell lines possessing acquired resistance to oxaliplatin. | 2002 Nov |
1 |
| 27 |
11925933 | Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarray. | 2001 Dec |
1 |
| 28 |
10918568 | Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells. | 2000 Jun 29 |
3 |
| 29 |
9889125 | Dependence on RAD52 and RAD1 for anticancer drug resistance mediated by inactivation of mismatch repair genes. | 1999 Jan 14 |
5 |
| 30 |
10048977 | Expression of DNA repair proteins hMSH2, hMSH6, hMLH1, O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistance. | 1999 Mar 1 |
2 |
| 31 |
10327053 | A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer. | 1999 Apr 8 |
4 |
| 32 |
10360646 | Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin. | 1999 May |
1 |
| 33 |
10408835 | Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents. | 1999 May |
1 |
| 34 |
10626357 | Specificity of platinum-DNA adduct repair. | 1999 Oct |
1 |
| 35 |
9647613 | Ongoing and unsaid on oxaliplatin: the hope. | 1998 Jun |
1 |
| 36 |
9721864 | The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. | 1998 Aug 15 |
3 |
| 37 |
9157971 | In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. | 1997 May 15 |
1 |
| 38 |
9233776 | hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents. | 1997 Jul 3 |
5 |
| 39 |
9815561 | Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells. | 1997 Oct |
1 |
| 40 |
8674066 | Loss of DNA mismatch repair in acquired resistance to cisplatin. | 1996 Jul 1 |
1 |
| 41 |
8895738 | The role of DNA mismatch repair in platinum drug resistance. | 1996 Nov 1 |
2 |